Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 314, Issue 3, Pages L349-L359
Publisher
American Physiological Society
Online
2017-11-16
DOI
10.1152/ajplung.00245.2017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostaglandin E 2 Inhibits Histamine-Evoked Ca 2+ Release in Human Aortic Smooth Muscle Cells through Hyperactive cAMP Signaling Junctions and Protein Kinase A
- (2017) Emily J. A. Taylor et al. MOLECULAR PHARMACOLOGY
- The anti-inflammatory effects of PGE2on human lung macrophages are mediated by the EP4receptor
- (2016) Sharonjit K Gill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A
- (2016) Ramy Habashy Malty et al. Journal of Neuroinflammation
- The molecular targets of approved treatments for pulmonary arterial hypertension
- (2015) Marc Humbert et al. THORAX
- Anti-inflammatory effects of PGE2in the lung: role of the EP4receptor subtype
- (2015) Mark A Birrell et al. THORAX
- Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase
- (2015) Ying-Ju Lai et al. PLoS One
- Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling
- (2014) Yuan Yang et al. MOLECULAR CARCINOGENESIS
- Ca2+signals evoked by histamine H1receptors are attenuated by activation of prostaglandin EP2and EP4receptors in human aortic smooth muscle cells
- (2013) Evangelia Pantazaka et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostaglandin E 2 Inhibits Elastogenesis in the Ductus Arteriosus via EP4 Signaling
- (2013) Utako Yokoyama et al. CIRCULATION
- E-type prostanoid receptor 4 (EP4) in disease and therapy
- (2013) Viktoria Konya et al. PHARMACOLOGY & THERAPEUTICS
- Important role of PLC-γ1 in hypoxic increase in intracellular calcium in pulmonary arterial smooth muscle cells
- (2012) Vishal R. Yadav et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Molecular pathogenesis of pulmonary arterial hypertension
- (2012) Marlene Rabinovitch JOURNAL OF CLINICAL INVESTIGATION
- Hypoxic Pulmonary Vasoconstriction
- (2012) J. T. Sylvester et al. PHYSIOLOGICAL REVIEWS
- Cilostazol Promotes Vascular Smooth Muscles Cell Differentiation Through the cAMP Response Element-Binding Protein-Dependent Pathway
- (2011) Wei-Jan Chen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mechanisms of disease: pulmonary arterial hypertension
- (2011) Ralph T. Schermuly et al. Nature Reviews Cardiology
- International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
- (2011) D. F. Woodward et al. PHARMACOLOGICAL REVIEWS
- Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs
- (2011) Zeenat Safdar RESPIRATORY MEDICINE
- EP4 receptor as a new target for bronchodilator therapy
- (2011) J. Buckley et al. THORAX
- Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension
- (2010) Emilia Falcetti et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
- (2009) et al. EUROPEAN HEART JOURNAL
- A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
- (2009) Kamal K. Mubarak RESPIRATORY MEDICINE
- Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension
- (2008) Ying-Ju Lai et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype
- (2008) N Foudi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
- (2008) Keiichi Hishikari et al. CARDIOVASCULAR RESEARCH
- An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension
- (2008) Georg Hansmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-γ: Therapeutic Implications for Cardiovascular Diseases
- (2007) Florence Gizard et al. PPAR Research
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started